These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22234513)

  • 1. N-terminal pro-brain natriuretic peptide could be a marker of subclinical atherosclerosis in patients with type 2 diabetes.
    Senmaru T; Fukui M; Tanaka M; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Heart Vessels; 2013 Mar; 28(2):151-6. PubMed ID: 22234513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.
    Hamano K; Nakadaira I; Suzuki J; Gonai M
    Vasc Health Risk Manag; 2014; 10():585-9. PubMed ID: 25328404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study.
    Chung YK; Lee YJ; Kim KW; Cho RK; Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
    Diab Vasc Dis Res; 2018 Jan; 15(1):24-30. PubMed ID: 29090609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus.
    Resl M; Clodi M; Neuhold S; Kromoser H; Riedl M; Vila G; Prager R; Pacher R; Strunk G; Luger A; Hülsmann M
    Diabet Med; 2012 Jun; 29(6):721-5. PubMed ID: 22050532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
    Hamano K; Abe M; Komi R; Kobayashi S
    Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Inada S; Mineoka Y; Nakanishi N; Senmaru T; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Atherosclerosis; 2012 Jan; 220(1):155-9. PubMed ID: 22100253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis.
    Reinhard H; Wiinberg N; Hansen PR; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
    Cardiovasc Diabetol; 2011 Aug; 10():71. PubMed ID: 21812947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.
    Cosson E; Nguyen MT; Pham I; Pontet M; Nitenberg A; Valensi P
    Diabet Med; 2009 Sep; 26(9):872-9. PubMed ID: 19719707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients.
    Reinhard H; Hansen PR; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
    Cardiovasc Diabetol; 2012 Mar; 11():19. PubMed ID: 22390472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.
    Grauslund J; Nybo M; Green A; Sjølie AK
    Scand J Clin Lab Invest; 2010 Oct; 70(6):392-8. PubMed ID: 20575653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal Pro-B-type Natriuretic Peptide is Associated with Arterial Stiffness as Measured According to the Brachial-ankle Pulse Wave Velocity in Patients with Takayasu Arteritis.
    Liu Q; Dang AM; Chen BW; Lv NQ; Wang X; Zheng DY
    J Atheroscler Thromb; 2015; 22(6):628-36. PubMed ID: 25503292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma NT-proBNP is independently associated with albuminuria in type 2 diabetes.
    Zhou L; Cai X; Li M; Han X; Ji L
    J Diabetes Complications; 2016; 30(4):669-74. PubMed ID: 26922580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-item version of the international index of erectile function correlated with albuminuria and subclinical atherosclerosis in men with type 2 diabetes.
    Fukui M; Tanaka M; Okada H; Iwase H; Mineoka Y; Senmaru T; Ohnishi M; Mogami S; Kitagawa Y; Yamazaki M; Hasegawa G; Nakamura N
    J Atheroscler Thromb; 2011; 18(11):991-7. PubMed ID: 21791882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.
    Shivananda Nayak B; Teelucksingh S; Jagessar A; Maharaj S; Maharaj N
    Diabetes Metab Syndr; 2013; 7(1):8-11. PubMed ID: 23517788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction.
    Görmüş U; Ozmen D; Ozmen B; Parildar Z; Ozdoğan O; Mutaf I; Bayindir O
    Diabetes Res Clin Pract; 2010 Jan; 87(1):51-6. PubMed ID: 19932518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Terminal Pro-Brain Type Natriuretic Peptide Predicts Cardiovascular Events Independently of Arterial Stiffness, Assessed By Carotid-to-Femoral Pulse Wave Velocity, in Apparently Healthy Subjects.
    Frary CE; Blicher MK; Olesen TB; Pareek M; Vishram-Nielsen JKK; Rasmussen S; Olsen MH
    Heart Lung Circ; 2024 Mar; 33(3):392-400. PubMed ID: 38290952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
    Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis).
    Mitchell A; Misialek JR; Folsom AR; Duprez D; Alonso A; Jerosch-Herold M; Sanchez OA; Watson KE; Sallam T; Konety SH
    Am J Cardiol; 2015 May; 115(10):1341-5. PubMed ID: 25816778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.